VTEQ ~ "FDA cleared" 5,000 women have now received
Post# of 85515
Posted On: 12/09/2014 11:47:18 PM
VTEQ ~ "FDA cleared" 5,000 women have now received....
DELRAY BEACH, Fla., Dec. 9, 2014 (GLOBE NEWSWIRE) -- VeriTeQ Corporation (OTC Markets:VTEQ) ("VeriTeQ"
a provider of implantable medical device identification and radiation dose measurement technologies, announced today that more than 5,000 women have now received Motiva Implant Matrix(R) breast implants, manufactured by Establishment Labs S.A. ("EL", with VeriTeQ's Q Inside Safety Technology(TM)
Past Developments for VeriTeQ (VTEQ)
November 24th 2014: VeriTeQ (VTEQ) announced that in conjunction with its customer Establishment Labs it will initiate development of a pressure-sensing microtransponder to be used in tissue expanders for breast reconstruction and tissue expansion.
November 5th 2014: VeriTeQ (VTEQ) announced new financing with New York investment firm Magna for up to $450,000.
October 15th 2014: VeriTeQ (VTEQ) announced that the Company and its breast implant customer, Establishment Labs planned to host a physician conference in Salzburg, Austria.
October 9th 2014: VeriTeQ (VTEQ) announced today that it has entered an agreement providing an exclusive license of multiple patents from North Carolina State University ("NCSU". VeriTeQ will license 24 patents, which are the foundation for its FDA cleared Q Inside SmartMarker and OneDose products for radiation dosimetry.
DELRAY BEACH, Fla., Dec. 9, 2014 (GLOBE NEWSWIRE) -- VeriTeQ Corporation (OTC Markets:VTEQ) ("VeriTeQ"
a provider of implantable medical device identification and radiation dose measurement technologies, announced today that more than 5,000 women have now received Motiva Implant Matrix(R) breast implants, manufactured by Establishment Labs S.A. ("EL", with VeriTeQ's Q Inside Safety Technology(TM) Past Developments for VeriTeQ (VTEQ)
November 24th 2014: VeriTeQ (VTEQ) announced that in conjunction with its customer Establishment Labs it will initiate development of a pressure-sensing microtransponder to be used in tissue expanders for breast reconstruction and tissue expansion.
November 5th 2014: VeriTeQ (VTEQ) announced new financing with New York investment firm Magna for up to $450,000.
October 15th 2014: VeriTeQ (VTEQ) announced that the Company and its breast implant customer, Establishment Labs planned to host a physician conference in Salzburg, Austria.
October 9th 2014: VeriTeQ (VTEQ) announced today that it has entered an agreement providing an exclusive license of multiple patents from North Carolina State University ("NCSU"
. VeriTeQ will license 24 patents, which are the foundation for its FDA cleared Q Inside SmartMarker and OneDose products for radiation dosimetry. 
(0)
(0)